Reversible Posterior Leukoencephalopathy Syndrome after Eribulin Mesylate Chemotherapy for Breast Cancer

Breast J. 2017 Jul;23(4):487-488. doi: 10.1111/tbj.12776. Epub 2017 Jan 31.

Authors

Young Mi Seol¹, Do Young Kim¹, Hyo Jeong Kim¹, Young Jin Choi¹

Affiliation

¹ Division of Hematology/Oncology, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

PMID: 28139871
DOI: 10.1111/tbj.12776

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents
Breast Neoplasms*
Humans
Posterior Leukoencephalopathy Syndrome*

Substances

Antineoplastic Agents